ABT Summary

  1. NYSE
  2. >
  3. ABT
TickerABT
DescriptionABBOTT LABORATORIES
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees107,000
Next Earnings DateJanuary 27th, 2021
IV29.405988%
IV Percentile57th
IV Rank27.86%
IV Skew7.420859
IV Skew Percentile49th
IV Skew SentimentNeutral
Option Volume12,142
Volume3,573,013
Price$107.85
Previous Close$109.48
52-Week High$114.195
52-Week Low$61.61
50-Day Moving Avg.$105.77
200-Day Moving Avg.$93.30
10-Day Avg. Volume4,288,307
20-Day Avg. Volume4,808,824
30-Day Avg. Volume4,810,055
3-Month Avg. Volume5,147,007
PE56.04762
EPS$1.73
Outstanding Shares1,770,530,000
Float1,755,354,787
Market Capitalization$187,552,242,800
CurrencyUSD
UpdatedOctober 23rd, 2020